Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof
Details for Australian Patent Application No. 2003265575 (hide)
International Classifications
Event Publications
18 December 2003 Complete Application Filed
Priority application(s): 60/404,802 19.08.02 US
22 April 2004 Application Open to Public Inspection
Published as AU-B-2003265575
20 September 2007 Assignment before Grant
Abgenix, Inc. The application has been assigned to AstraZeneca AB 2004
10 December 2009 Application Accepted
Published as AU-B-2003265575
8 April 2010 Standard Patent Sealed
17 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003265576-CORTICOSTEROID CONJUGATES AND USES THEREOF
2003265574-EXPRESSION VECTORS ENCODING EPITOPES OF TARGET-ASSOCIATED ANTIGENS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser